(4S,20S,22R)-19,27-di-p-chlorobenzoyloxy-4β-hydroxy-5β,6β-epoxy-1-oxowitha-2,24-dienolide | 1391916-35-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 类固醇和类固醇衍生物
• 英文名称: (4S,20S,22R)-19,27-di-p-chlorobenzoyloxy-4β-hydroxy-5β,6β-epoxy-1-oxowitha-2,24-dienolide
• 英文别名: withalongolide A 19,27-di-p-chlorobenzoate；[(2R)-2-[(1S)-1-[(1S,2S,6S,7R,9R,11S,12S,15R,16S)-2-[(4-chlorobenzoyl)oxymethyl]-6-hydroxy-16-methyl-3-oxo-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-15-yl]ethyl]-4-methyl-6-oxo-2,3-dihydropyran-5-yl]methyl 4-chlorobenzoate
• CAS: 1391916-35-0
• 化学式: C₄₂H₄₄Cl₂O₉
• 分子量: 763.712
• InChiKey: UMKOFTDMVBCXNY-GSWROJNRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  7.8
• 重原子数：
  53
• 可旋转键数：
  10
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  129
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  withalongolide A 、 4-氯苯甲酰氯 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 1.0h， 以10%的产率得到(4S,20S,22R)-4β-p-chlorobenzoyloxy-19,27-dihydroxy-5β,6β-epoxy-1-oxowitha-2,24-dienolide
  参考文献：
  名称：

  Synthesis and Cytotoxicity of Semisynthetic Withalongolide A Analogues

  摘要：

  The natural product withaferin A exhibits potent antitumor activity and other diverse pharmacological activities. The recently discovered withalongolide A, a C-19 hydroxylated congener of withaferin A, was recently reported to possess cytotoxic activity against head and neck squamous cell carcinomas. Semisynthetic acetylated analogues of withalongolide A were shown to be considerably more cytotoxic than the parent compound. To further explore the structure activity relationships, 20 new semisynthetic analogues of withalongolide A were synthesized and evaluated for cytotoxic activity against four different cancer cell lines. A number of derivatives were found to be more potent than the parent compound and withaferin A.

  DOI：

  10.1021/ml400267q

文献信息

• Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof
  申请人：Timmermann Barbara N.

  公开号：US20120196815A1

  公开（公告）日：2012-08-02

  The present invention features novel withanolides, as well as analogs and salts thereof, for use in the treatment of proliferative disease, cardiovascular disease, neurodegenerative disease and inflammatory disease.